Minerva Neurosciences
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NERV and other ETFs, options, and stocks.About NERV
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease.
NERV Key Statistics
Stock Snapshot
With a market cap of 209.88M, Minerva Neurosciences(NERV) trades at $4.51. The stock has a price-to-earnings ratio of -0.15.
During the trading session on 2026-06-14, Minerva Neurosciences(NERV) shares reached a daily high of $4.78 and a low of $4.40. At a current price of $4.51, the stock is +2.5% higher than the low and still -5.6% under the high.
Trading volume for Minerva Neurosciences(NERV) stock has reached 82.9K, versus its average volume of 105.51K.
Over the past 52 weeks, Minerva Neurosciences(NERV) stock has traded between a high of $12.46 and a low of $1.57.
Over the past 52 weeks, Minerva Neurosciences(NERV) stock has traded between a high of $12.46 and a low of $1.57.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.